SOCS1 and SOCS3 expression is reduced in tumor lesions of BCC and SCC, as compared to other skin inflammatory conditions such as psoriasis, despite the high number of IL-22-secreting tumor-infiltrating lymphocytes (85). This evidence concerns the gene IL22 and skin basal cell carcinoma.